Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene
El-Harith Abdelghaffar El-Harith
Institute of Human Genetics
These authors contributed equally to the study.
Search for more papers by this authorCornelia Roesl
Institute of Human Genetics
These authors contributed equally to the study.
Search for more papers by this authorMatthias Ballmaier
Department of Paediatric Haematology and Oncology
Search for more papers by this authorManuela Germeshausen
Department of Paediatric Haematology and Oncology
Search for more papers by this authorNils Von Neuhoff
Department of Cell and Molecular Pathology, Medical University of Hannover, Hannover
Search for more papers by this authorChristian Becker
Cologne Centre for Genomics and Institute for Genetics
Search for more papers by this authorGudrun Nürnberg
Cologne Centre for Genomics and Institute for Genetics
Search for more papers by this authorPeter Nürnberg
Cologne Excellence Cluster on Cellular Stress Responses in Ageing-associated Diseases (CECAD), University of Cologne, Cologne, Germany
Search for more papers by this authorMirghani Ali Mohamed Ahmed
College of Medicine, University of Khartoum, Khartoum, Sudan
Search for more papers by this authorJeannette Hübener
Institute of Human Genetics
Present address: J. Hübener, Department of Medical Genetics, University Tuebingen, Germany.
Search for more papers by this authorEl-Harith Abdelghaffar El-Harith
Institute of Human Genetics
These authors contributed equally to the study.
Search for more papers by this authorCornelia Roesl
Institute of Human Genetics
These authors contributed equally to the study.
Search for more papers by this authorMatthias Ballmaier
Department of Paediatric Haematology and Oncology
Search for more papers by this authorManuela Germeshausen
Department of Paediatric Haematology and Oncology
Search for more papers by this authorNils Von Neuhoff
Department of Cell and Molecular Pathology, Medical University of Hannover, Hannover
Search for more papers by this authorChristian Becker
Cologne Centre for Genomics and Institute for Genetics
Search for more papers by this authorGudrun Nürnberg
Cologne Centre for Genomics and Institute for Genetics
Search for more papers by this authorPeter Nürnberg
Cologne Excellence Cluster on Cellular Stress Responses in Ageing-associated Diseases (CECAD), University of Cologne, Cologne, Germany
Search for more papers by this authorMirghani Ali Mohamed Ahmed
College of Medicine, University of Khartoum, Khartoum, Sudan
Search for more papers by this authorJeannette Hübener
Institute of Human Genetics
Present address: J. Hübener, Department of Medical Genetics, University Tuebingen, Germany.
Search for more papers by this authorSummary
Familial thrombosis (FT) has been described as a rare autosomal-dominant disorder, mostly caused by activating mutations of the thrombopoietin gene (THPO). Other cases of FT have been linked to one of two different germline mutations in the myeloproliferative leukaemia virus oncogene gene (MPL), which codes for the thrombopoietin receptor MPL. We studied an Arab family with two siblings with severe thrombocytosis by linkage analysis and obtained evidence for linkage to MPL. Sequencing revealed homozygosity for the novel MPL germline mutation p.Pro106Leu (c.317C > T) in the two siblings. Subsequently, homozygosity for p.Pro106Leu was identified in six further FT patients from three other Arab families. Of 18 heterozygous carriers, 14 had normal platelet counts, while four had mild thrombocytosis. Strong support for association of the novel MPL mutation p.Pro106Leu with development of familial thrombocytosis has been obtained. Overall, p.Pro106Leu was absent on 386 alleles of 193 healthy German controls and present on 14 of 426 alleles (3·3%) of 213 unrelated Arabs, which was statistically significantly different (P < 0·001, Fisher’s exact test). We assume that p.Pro106Leu is a frequent MPL mutation in the Arab population, leading to severe thrombocytosis in homozygotes and occasionally to mild thrombocytosis in heterozygotes. In the families described the mode of inheritance could be regarded as autosomal-recessive with possible mild heterozygote manifestation rather than autosomal-dominant with high penetrance as usually seen in FT.
Supporting Information
Figure S1. LOD score for the MPL region on chromosome 1. Coordinate 0 cM (centi Morgan) at the X-axis equals 52.1 cM at the deCODE genetic map (Kong et al, 2002). A LOD (logarithm of the odds) score of 2.18 was calculated for a candidate region of 27.4 cM (54.9 to 82.3 cM at the deCODE genetic map). MPL is located within the candidate region at 67.8 cM (approximately at coordinate 16.6 cM at the X-axis).
Figure S2. Surface expression of MPL on platelets. Platelets of a normal donor with MPL wild type sequence (ND), of patients VI3 and VI5 with homozygous p.Pro106Leu mutation and their heterozygously mutated parents (V8 and V9) were stained either with a monoclonal antibody (clone AHM21, upper row) or a polyclonal rabbit antiserum against the extracellular domain of human MPL. Grey curves: unspecific control, Black curves: specific antibody.
Table SI. Primer sequences, fragment lengths and annealing temperatures for microsatellite markers linked to the candidate genes THPO, MPL and JAK2. The forward primers (above) were 5′end labelled with fluorescent dye fluorescein.
Table SII. Primer sequences, fragment lengths and annealing temperatures for MPL PCR and sequencing.
Table SIII. Marker analysis at the MPL locus. ID-numbers of patients with FT are written in bold. MPL extends from 43,576 to 43,592 kB (NC_000001.9 NCBI Reference assembly). Markers D1S545 and D1S447 were informative. The affected family members VI:3 and VI:5 were concordant for both parental alleles.
Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
Filename | Description |
---|---|
BJH_7430_sm_FigS1.pdf555.4 KB | Supporting info item |
BJH_7430_sm_TableSI-III.doc126.5 KB | Supporting info item |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- Abecasis, G.R., Cherny, S.S., Cookson, W.O. & Cardon, L.R. (2001) GRR: graphical representation of relationship errors. Bioinformatics, 17, 742–743.
- Abecasis, G.R., Cherny, S.S., Cookson, W.O. & Cardon, L.R. (2002) Merlin – rapid analysis of dense genetic maps using sparse gene flow trees. Nature Genetics, 30, 97–101.
- Ballmaier, M., Germeshausen, M., Schulze, H., Cherkaoui, K., Lang, S., Gaudig, A., Krukemeier, S., Eilers, M., Strauss, G. & Welte, K. (2001) c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood, 97, 139–146.
- Carpinelli, M.R., Hilton, D.J., Metcalf, D., Antonchuk, J.L., Hyland, C.D., Mifsud, S.L., Di Rago, L., Hilton, A.A., Willson, T.A., Roberts, A.W., Ramsay, R.G., Nicola, N.A. & Alexander, W.S. (2004) Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proceedings of the National Academy of Science, USA, 101, 6533–6558.
- Cazzola, M. (2008) Molecular basis of thrombocytosis. Haematologica, 93, 646–648.
- Croft, J.B. & Swift, M. (1990) Obesity, hypertension, and renal disease in relatives of Bardet–Biedl syndrome sibs. American Journal of Medical Genetics, 36, 37–42.
-
Dame, C. (2006) Thrombocytosis. In: Pediatric Hematology (ed. by
R. Arcesi,
J.M. Hann &
O.P. Smith), pp. 548–561. Blackwell Publishing, Oxford, UK.
10.1002/9780470987001.ch24 Google Scholar
- Ding, J., Komatsu, H., Wakita, A., Kato-Uranishi, M., Ito, M., Satoh, A., Tsuboi, K., Miyazaki, H., Iida, S. & Ueda, R. (2004) Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood, 103, 4198–4200.
- Fryns, J.P. (1991) Postaxial polydactyly as heterozygote manifestation in Ellis-van Crefeld syndrome? American Journal of Medical Genetics, 39, 500.
- Fryns, J.J., Kleczkowska, A., Dereymaeker, A.M., Hoefnagels, M., Heremans, G., Marien, J. & Van Den Berghe, H. (1986) A genetic-diagnostic survey in an institutionalized population of 173 severely metally retarded patients. Clinical Genetics, 30, 315–323.
- Fujiwara, T., Harigae, H., Kameoka, J., Yokoyama, H., Takahashi, S., Tomiya, Y., Yamada, M., Ishizawa, K., Imaizumi, M. & Sasaki, T. (2004) A case of familial thrombocytosis: possible role of altered thrombopoietin production. American Journal of Hematology, 76, 395–397.
- Germeshausen, M., Ballmaier, M. & Welte, K. (2006) MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Human Mutation, 27, 296.
- Ghilardi, N. & Skoda, R.C. (1999) A single base deletion in the thrombopoietin (TPO) gene causes familial essential thrombocythemia through a mechanism of more efficient translation of TPO mRNA. Blood, 94, 1480–1482.
- Ghilardi, N., Wiestner, A., Kikuchi, M., Ohsaka, A. & Skoda, R.C. (1999) Hereditary thrombocythemia in a Japanese family is caused by a novel point mutation in the thrombopoietin gene. British Journal of Haematology, 107, 310–316.
- Gudbjartsson, D.F., Jonasson, K., Frigge, M.L. & Kong, A. (2000) Allegro, a new computer program for multipoint linkage analysis. Nature Genetics, 25, 12–13.
- Kondo, T., Okabe, M., Sanada, M., Kurosawa, M., Sachiko, S., Suzuki, S., Kobayashi, M., Hosokawa, M. & Asaka, M. (1998) Familial essential thrombocythemia associated with one-base deletion in the 5′-untranslated region of the thrombopoietin gene. Blood, 92, 1091–1096.
- Kong, A., Gudbjartsson, D.F., Sainz, J., Jonsdottir, G.M., Gudjonsson, S.A., Richardsson, B., Sigurdardottir, S., Barnard, J., Hallbeck, B. & Masson, G. (2002) A high-resolution recombination map of the human genome. Nature Genetics, 31, 241–247.
- Kunishima, S., Mizuno, S., Naoe, T., Saito, H. & Kamiya, T. (1998) Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia: a case study. British Journal of Haematology, 100, 383–386.
- Liu, K., Kralowics, R., Rudzki, Z., Grabowska, B., Buser, A.S., Olcaydu, D., Gisslinger, H., Tiedt, R., Frank, P., Okon, K., Van Der Maas, A.P.C. & Skoda, R.C. (2008) A de novo splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia in a Polish family. Haematologica, 93, 706–714.
- Moliterno, A.R., Williams, D.M., Guiterrez-Alamillo, L.I., Salvatori, R., Ingersoll, R.G. & Spivak, J.L. (2004) Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis. Proceedings of the National Academy of Science, 101, 11444–11447.
- O’Connell, J.R. & Weeks, D.E. (1998) PedCheck: a program for identification of genotype incompatibilities in linkage analysis. American Journal of Human Genetics, 63, 259–266.
- Onishi, M., Mui, A.L., Morikawa, Y., Cho, L., Kinoshita, S., Nolan, G.P., Gorman, D.M., Miyajima, A. & Kitamura, T. (1996) Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood, 88, 1399–1406.
- Pardanani, A.D., Levine, R.L., Lasho, T., Pikman, Y., Mesa, R.A., Wadleigh, M., Steensma, D.P., Elliott, M.A., Wolanskyj, A.P., Hogan, W.J., McClure, R.F., Litzow, M.R., Gilliland, D.G. & Tefferi, A. (2006) MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1152 patients. Blood, 108, 3472–3476.
- Pikman, Y., Lee, B.H., Mercher, T., McDowell, E., Ebert, B.L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., DeAngelo, D.J., Clark, J.J., Lee, S.J., Golub, T.R., Wadleigh, M., Gilliland, D.G. & Levine, R.L. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Medicine, 3, e270.
- Rüschendorf, F. & Nürnberg, P. (2005) alohomora: a tool for linkage analysis using 10K SNP array data. Bioinformatics, 21, 2123–2125.
- Pikman, Y., Lee, B.H., Mercher, T., McDowell, E., Ebert, B.L., Gozo, M., Cuker, A., Wernig, G., Moore, S., Galinsky, I., DeAngelo, D.J., Clark, J.J., Lee, S.J., Golub, T.R., Wadleigh, M., Gilliland, D.G. & Levine, R.L. (2006) MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Medicine, 3, e270.
- Rüschendorf, F. & Nürnberg, P. (2005) ALOHOMORA: a tool for linkage analysis using 10K SNP array data. Bioinformatics, 21, 2123–2125.
- Skoda, R. & Prchal, J. (2005) Lessons from familial myeloproliferative disorders. Seminars in Hematology, 8, 266–273.
- Stuhrmann, M., Bashawri, L., Ahmed, M.A., Al-Awami, B.H., Kuhnau, W., Schmidtke, J. & El-Harith, E.A. (2001) Familial thrombocytosis as a recessive, possibly X-linked trait in an Arab family. British Journal of Haematology, 112, 616–620.
- Tecuceanu, N., Dardik, R., Rabizadeh, E., Raanani, P. & Inbal, A. (2006) A family with hereditary thrombocythaemia and normal genes for thrombopoietin and c-Mpl. British Journal of Haematology, 135, 348–351.
- Teofili, L., Giona, F., Martini, M., Cenci, T., Guidi, F., Torti, L., Palombo, G., Amendola, A., Foá, R. & Larocca, L.M. (2007) Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. Journal of Clinical Oncology, 9, 1048–1053.
- Thiele, H. & Nürnberg, P. (2005) HaploPainter: a tool for drawing pedigrees with complex haplotypes. Bioinformatics, 21, 1730–1732.
-
Vannucchi, A.M. &
Barbui, T. (2007) Thrombocytosis and thrombosis.
Hematology American Society of Hematology Education Program, 2007, 363–370.
10.1182/asheducation-2007.1.363 Google Scholar
- Vogel, F. (1984) Clinical consequences of heterozygosity for autosomal-recessive diseases. Clinical Genetics, 25, 381–415.
- Wiestner, A., Schlemper, R.J., Van Der Maas, A.P.C. & Skoda, R.C. (1998) An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythemia. Nature Genetics, 18, 49–52.
- Wiestner, A., Padosch, S.A., Ghilardi, N., Cesar, J.M., Odriozola, J., Shapiro, A. & Skoda, R.C. (2000) Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia. British Journal of Haematology, 110, 104–109.